Glaucoma

LondonOC develops new, non-invasive technique to apply Xen stent into the eye

1 month ago   |   News Medical

The London Ophthalmology Centre has developed a new, non-invasive technique for the application of Xen stent into the eye to treat acute glaucoma. The micro device and new...
Read more ...

Bimatoprost implant reduces IOP in glaucoma

Bimatoprost implant reduces IOP in glaucoma

1 month ago   |   Healio

LAS VEGAS - Patients with glaucoma showed high response rates after receiving a bimatoprost implant to reduce IOP, according to research presented at the American Society of...
Read more ...

Omni surgical system reduces IOP, medication use

Omni surgical system reduces IOP, medication use

1 month ago   |   Healio   |   3 articles

LAS VEGAS - The Omni surgical system reduced IOP through 3 months in patients with open-angle glaucoma, according to research presented at the American Society of Cataract and...
Read more ...

Role of Gene Therapy in Preventing Blindness

Role of Gene Therapy in Preventing Blindness

1 month ago   |   Medindia Health

New gene therapy can be a valuable therapeutic target to save retinal ganglion cells and preserve vision in treating potentially blinding diseases like glaucoma.
Read more ...

Neuroprotection key to long-term glaucoma therapy

Neuroprotection key to long-term glaucoma therapy

1 month ago   |   Healio

LAS VEGAS -Finding treatment options for glaucoma beyond IOP lowering may be the future course toward preventing blindness in glaucoma, according to a speaker here. “Remember...
Read more ...

Hypotony severity affects management in patients undergoing cataract surgery

Hypotony severity affects management in patients undergoing cataract surgery

1 month ago   |   Healio

LAS VEGAS - Effective strategies to treat hypotony in patients with prior trabeculectomy who are undergoing cataract surgery vary depending on severity, according to a speaker...
Read more ...

Gene therapy protects optic nerve cells and preserves vision in glaucoma mouse models

1 month ago   |   News Medical

A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH's National Eye Institute.
Read more ...

Scientists discover gene therapy provides neuroprotection to prevent glaucoma vision loss

1 month ago   |   ScienceDaily   |   4 articles

A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to new research. The findings suggest a way forward for developing...
Read more ...

Polygenic-Variant Testing Can Help Improves Glaucoma-Risk Prediction

1 month ago   |   Medscape   |   2 articles

Polygenic risk scores can improve risk stratification in people at increased odds of developing open-angle glaucoma, according to researchers in Australia. Reuters Health...
Read more ...

VJCRGS.com: Video-based journal highlights ASCRS Film Festival

VJCRGS.com: Video-based journal highlights ASCRS Film Festival

2 monthes ago   |   Healio

The latest issue of the Video Journal of Cataract, Refractive, and Glaucoma Surgery, whose mission is to advance the knowledge and surgical training of eye surgeons through...
Read more ...


Register you to post on Health Mag

Free Registration

Cholangiopathy after severe COVID-19 may lead to liver injury, failure

Cholangiopathy after severe COVID-19 may lead to liver injury, failure

For patients with severe COVID-19, cholangiopathy was a late complication with potential for progressive biliary injury or liver failure, according to a study published in the... Read more ...

Mississippi woman pleads others to get vaccinated as her husband is hospitalized

Mississippi woman pleads others to get vaccinated as her husband is hospitalized

William Thomas Ball, 51, has been hospitalized with COVID-19 in Jackson, Mississippi after refusing to get vaccinated. Now his wife, Alicia, is asking for others in her... Read more ...

Covid England: Cases are now falling in ALL age groups, official data reveals

Covid England: Cases are now falling in ALL age groups, official data reveals

EXCLUSIVE: Covid cases are falling in all age groups, and dropping fastest among adults in their twenties according to data from the Department of Health. Read more ...

Lumbar artificial disc yielded positive 7-year outcomes for degenerative...

Lumbar artificial disc yielded positive 7-year outcomes for degenerative disc disease

For total disc replacement in patients with degenerative disc disease, an artificial disc is a safe option that improves pain relief, function, range of motion and decreases in... Read more ...

FDA clamps down on imported shark fins, cantaloupes, mushrooms and more

FDA clamps down on imported shark fins, cantaloupes, mushrooms and more

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as... Read more ...

FDA TechTalk podcast episode to focus on whole genome sequencing

FDA TechTalk podcast episode to focus on whole genome sequencing

Nowadays, it seems rare to find someone or some entity without a podcast, and the Food and Drug Administration is no exception. The TechTalk podcast is hosted by the FDA and... Read more ...

COVID Breakthrough Cases Ran the Gamut in Healthcare Workers

COVID Breakthrough Cases Ran the Gamut in Healthcare Workers

Breakthrough COVID-19 cases in fully vaccinated healthcare workers were rare, and generally were associated with the individual's immune response to the vaccine in the early... Read more ...

Some IBD Treatments in Pregnancy Had No Effect on Kids' Infection Risk

Some IBD Treatments in Pregnancy Had No Effect on Kids' Infection Risk

Exposure to immunosuppressive monotherapies in utero did not increase serious infection risks in young children born to mothers with inflammatory bowel disease , but the same... Read more ...

FDA issues complete response letter for retifanlimab for anal cancer

FDA issues complete response letter for retifanlimab for anal cancer

The FDA issued a complete response letter to Incyte indicating it cannot approve the company's biologics license application that seeks approval of retifanlimab for certain... Read more ...

Bristol Myers Squibb withdraws liver cancer indication for nivolumab

Bristol Myers Squibb withdraws liver cancer indication for nivolumab

Bristol Myers Squibb in consultation with the FDA voluntarily withdrew the indication for nivolumab as monotherapy for patients with hepatocellular carcinoma previously treated... Read more ...